Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Theralase Technologies Inc. V.TLT.W


Primary Symbol: V.TLT Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Recent & Breaking News (TSXV:TLT)

Theralase Presents Latest Scientific Research at 15th International Photodynamic Association World Congress

Filing Services Canada May 27, 2015

Theralase to Present at the 2015 Marcum Microcap Conference

Filing Services Canada May 26, 2015

Microcap Report: Alabama Graphite active on U.S. graphene discovery

Stockhouse Editorial May 14, 2015

Theralase Discovers Anti-Cancer Drug Fluoresces in Tissue

Accesswire May 14, 2015

Theralase Discovers Anti-Cancer Drug Fluoresces in Tissue

Filing Services Canada May 14, 2015

Theralase Manufactures High Purity Anti-Cancer Drug

Filing Services Canada May 12, 2015

Theralase Increases Revenue 15% in 2014 Financials

TheNewsWire May 1, 2015

Theralase (V.TLT) produces first pre-commercial lot of lead anti-cancer drug

Stockhouse Editorial April 9, 2015

Theralase Manufactures First Pre-Commercial Batch of Lead Anti-Cancer Drug

TheNewsWire April 9, 2015

Theralase Holds pre-CTA Meeting with Health Canada

TheNewsWire April 2, 2015

Theralase Partners with CiToxLAB for Toxicology

TheNewsWire March 23, 2015

Bionic biotech: T-Bird Pharma (V.TPI) up 69% in 7 days, VANC Pharma (V.NPH) up 333% in a month

Chris Parry March 12, 2015

Theralase Confirms Strategic Initiatives

TheNewsWire March 11, 2015

Theralase Announces Completion of Public Offering of Units

Marketwired March 3, 2015

Microcap Report: Theralase Tech (V.TLT) active on proposed unit offering

Stockhouse Editorial February 25, 2015

Theralase Announces Proposed Public Offering of Units

Marketwired February 24, 2015

Theralase Identifies Potential Mechanism of How Lead Anti-Cancer Drug Works to Destroy Cancer and Discovers New Application to Detect Cancer Cells

TheNewsWire February 23, 2015

Theralase (V.TLT) lead anti-cancer drug much less toxic than FDA-approved drug

Stockhouse Editorial February 13, 2015

Theralase's Lead Anti-Cancer Drug Has Significantly Less Skin Toxicity than FDA Approved Drug

TheNewsWire February 13, 2015

Theralase Ranked in 2015 Toronto Stock Exchange Venture 50(tm)

TheNewsWire February 11, 2015